Because the experiments using the R6 mouse models were carried out before the overt neurological phenotype emerged, the down-regulation of GLT1 appears to persist throughout the progression of HD and is a likely contributor to neurodegeneration. This evidence concerns the gene SLC1A2 and Huntington disease.